The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGR.L Regulatory News (MGR)

  • There is currently no data for MGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

18 Oct 2019 09:21

RNS Number : 3774Q
Nplus1 Singer Capital Markets Ltd
18 October 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Miton Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Miton Group Plc

(d) Date dealing undertaken:

17 October 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.1P

 

 

Purchase

 

490

 

53.785p

 

53.785p

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

18 October 2019

Contact name:

Nick Wright

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERMMMMGRRLGLZG
Date   Source Headline
10th Nov 201711:01 amRNSHolding(s) in Company
6th Nov 20175:18 pmRNSHolding(s) in Company
1st Nov 201712:20 pmPRNForm 8.3 - Clinigen Group Plc
31st Oct 20178:06 amRNSDirector dealings
26th Oct 20174:53 pmRNSHolding(s) in Company
25th Oct 201711:23 amRNSDirector dealings
23rd Oct 201710:24 amPRNForm 8.3 - Belvoir Lettings Plc
23rd Oct 201710:12 amPRNForm 8.3 - Property Franchise Group PLC
19th Oct 20174:43 pmRNSHolding(s) in Company
19th Oct 20172:53 pmRNSHolding(s) in Company
19th Oct 20171:54 pmRNSHolding(s) in Company
18th Oct 20179:37 amRNSExchange of shares under the Growth Share Plan
16th Oct 20175:29 pmRNSHolding(s) in Company
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20171:20 pmRNSHolding(s) in Company
27th Sep 20172:54 pmRNSHolding(s) in Company
25th Sep 20173:37 pmRNSHolding(s) in Company
22nd Sep 201712:05 pmRNSHolding(s) in Company
21st Sep 20173:31 pmRNSDirector dealings
21st Sep 20179:33 amRNSHolding(s) in Company
21st Sep 20177:01 amRNSHalf-year Report
21st Sep 20177:00 amRNSDirectorate Change
20th Sep 201710:15 amRNSHolding(s) in Company
15th Sep 20172:00 pmRNSHolding(s) in Company
15th Sep 20179:39 amRNSHolding(s) in Company
14th Sep 20174:10 pmRNSHolding(s) in Company
11th Sep 20179:56 amPRNForm 8.3 - Novae Group Plc
8th Sep 20175:00 pmRNSHolding(s) in Company
7th Sep 20172:21 pmRNSHolding(s) in Company
6th Sep 20177:00 amRNSHolding(s) in Company
4th Sep 201712:07 pmRNSHolding(s) in Company
1st Sep 20173:44 pmRNSHolding(s) in Company
1st Sep 20173:28 pmRNSHolding(s) in Company
30th Aug 20175:18 pmRNSHolding(s) in Company
30th Aug 20174:09 pmRNSDirector/PDMR Shareholding
24th Aug 20173:55 pmRNSTR-1: Notification of Major Interest in Shares
22nd Aug 201712:04 pmRNSHolding(s) in Company
18th Aug 201710:10 amRNSHolding(s) in Company
17th Aug 20174:06 pmPRNForm 8 (OPD) Quantum Pharma Plc
17th Aug 201711:23 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSHolding(s) in Company
9th Aug 201712:40 pmRNSHolding(s) in Company
3rd Aug 20178:42 amRNSTR1 - Notification of Major Holdings
28th Jul 20178:25 amRNSHolding(s) in Company
27th Jul 20175:36 pmRNSDirector dealings
24th Jul 20172:05 pmRNSHolding(s) in Company
20th Jul 20174:55 pmRNSHolding(s) in Company
19th Jul 20175:16 pmRNSHolding(s) in Company
12th Jul 201711:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.